期刊文献+

代谢综合征周围动脉硬化特征及对其综合干预的影响 被引量:4

Effects of comprehensive intervention in peripheral arteriosclerotic occlusive disease of patients with metabolic syndrome
下载PDF
导出
摘要 目的探讨综合干预对代谢综合征(MS)患者周围动脉硬化症的影响.方法收集2002~2005年就诊的患者352例,MS组252例、高血压病(EH组)49例和2型糖尿病(T2DM组)51例,将接受综合干预的199例患者作为干预组,尚未综合干预的153例患者作为对照组,测量腹围(WC)、体重指数(BMI)、血压(BP)、血糖、血脂等指标,比较两组踝肱指数(ABPI)的变化情况.结果周围动脉狭窄的患者空腹血糖(FPG)、甘油三酯(TG)、WC、SBP较正常组显著增高,周围动脉钙化的患者FPG、TG、BMI、WC和DBP水平较正常组显著增高;综合干预组的患者BMI、低密度脂蛋白胆固醇(LDL-C)、DBP和FPG水平较对照组明显降低,而高密度脂蛋白胆固醇(HDL-C)明显增高;干预组周围动脉硬化发生率较对照组明显降低(P<0.05 );周围动脉硬化患者中吸烟率明显高于未发生周围动脉硬化者,而规律运动者的比例明显低于未发生周围动脉硬化者(P<0.05).结论生活方式改善和药物的综合干预,能有效控制MS的部分组分,降低周围动脉硬化症的风险. Objective To evaluate the effects of comprehensive intervention in peripheral arteriosclerotic occlusive disease (PAOD) of patients with metabolic syndrome. Methods 352 patients were enrolled in this study, who were admitted to hospital with the initial diagnosis of type 2 diabetes mellitus (T2DM, 51 cases), essential hypertension (EH, 49 cases), or metabolic syndrome (MS, 252 cases). Among them 199 patients were comprehensively intervened and the other 153 were not to serve as controls. The abdominal circumference, BMI, blood pressure, blood sugar and plasma lipid were measured and the effects of intervention were evaluated. Results Patients with stenosis of peripheral arteries had higher FPG, TG, WC and SBP levels, and the patients of arteriosteogenesis had higher FPG, TG, BMI, WC and DBP levels. Compared with the control group, the levels of BMI, LDL-C, DBP, and FPG, as well as the incidence of arteriosclerosis obviously declined in the intervention group (P〈0. 05), while that of HDL-C elevated. Comparing between the smokers and nonsmokers, the incidence of arteriosclerosis was markedly higher in the former than in the latter. However, when comparison was done between the persons with and without regular exercises, it was found that the incidence of arteriosclerosis was significantly lower in the former than in the latter. Conclusions Most of MS components were obviously improved by the comprehensive intervention regimen, and the risk of arteriosclerosis could be decreased.
机构地区 [
出处 《解放军医学杂志》 CAS CSCD 北大核心 2005年第8期693-695,共3页 Medical Journal of Chinese People's Liberation Army
基金 国家自然科学基金
关键词 代谢综合征 动脉硬化 综合干预 metabolic sydrome arteriosclerosis comprehensive intervention
  • 相关文献

参考文献9

  • 1Ford ES,Giles WH,Dietz WH et al.Prevalence of the metabolic syndrome among US adults:findings from the third National Health and Nutrition Exam ination Survey.JAMA,2002,287:356.
  • 2Orchard TJ,Strandness Jr DE.Assessment of peripheral vascular disease in diabetes.Diabetes Care,1993,16:1199.
  • 3Takolander R,Rauwarda JA.The use of non2invasive vascular assessment in diabetic patients with foot leisions.Diabec Med,1996,13:S39.
  • 4Resnick HE,Lindsay RS,McMermott MM et al.Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality.Circulation,2004,109:733.
  • 5Boyko EJ,Fujimoto WF,Leonetti DL.Visceral adiposity and risk of type 2 diabetes,a prospective study among Japanese Americans.Diabetes Care,2000,23∶465.
  • 6Bosello O,Zamboni M.Visceral obesity and metabolic syndrome.Obes Rev,2000,1:47.
  • 7Nordskog BK,Blixt AD,Morgan WT et al.Matrix-degrading and pro-inflammatory changes in human vascular endothelial cells exposed to cigarette smoke condensate.Cardiovasc Toxicol,2003,3(2):101.
  • 8樊瑾,李小鹰,朱平.我国老年男性高血压病合并周围动脉硬化闭塞性疾病相关因素的初步研究[J].军医进修学院学报,2002,23(2):142-144. 被引量:7
  • 9Solymoss BC,Bourassa MG,Campeau L et al.Effect of increasing metabolic syndrome score on atherosclerosis risk profile and coronary artery disease angiographic severity.AmJ Cardiol,2004,93 :159.

二级参考文献8

  • 1[1]Jeffery I John Byrne. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: A critical review [J]. Circulation.1996,94: 3026-3049.
  • 2[2]Malinow MR, Kang SS Taylor LM Jr, et al. Prevalence of hyperhomocysteinemia in patients with peripheral arterial disease[J]. Circulation, 1989, 79: 1180-1188.
  • 3[3]Lloyd M Taylor Jr, Gregory L Moneta, Gary J Sexton, et al.Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease[J]. J Vasc Surg, 1999,29:8-21.
  • 4[4]Harris LM, Armstrong D.Premature peripheral vascular disease: clinical profile and abnormal lipid peroxidation[J]. Cardiovasc Surg,1998, 6(2): 188-193.
  • 5[5]O′Neal DN,Lewicki J.Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects[J]. Atherosclerosis,1998, 136(1): 1-8.
  • 6[6]Graham IM,Daly LE. Plasma homocysteine as a risk factor for vascular disease[J]. JAMA, 1997, 277: 1775-1781.
  • 7[7]Melton LJ,Macken KM. Incidence and prevalence of clinical peripheral vascular disease in a population-based cohort of diabetic patients[J]. Diabetes Care, 1980,3: 650-654.
  • 8[8]Kannel WB,McGhee DL. Update on some epidemiological features of intermittent claudication: the Framingham study[J]. J Am Geriatr Soc, 1984,33: 13-18.

共引文献6

同被引文献66

引证文献4

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部